Consilient Health has launched Rewisca (pregabalin) for adjunctive therapy in adults with partial seizures and treatment of Generalised Anxiety Disorder.
Novozymes Biopharma, part of Novozymes A/S, announced that an ophthalmic solution made using its recombinant human albumin has been approved for Phase I/II development by the FDA.
